8Gorelik O,Almoznino-Sarafian D,Yarovoi I,et al.Patient-dependent variables affecting treatment and prediction of acute coronary syndrome are age-related.A study performed in Israel[J].Int J Cardiol,2007,121:163.
9Cohen M.Strategies for optimizing outcomes in the NSTE-ACS patient the CATH(cardiac catheterization and antithrombotic therapy in the hospital) clinical consensus panel report[J].Journal of Invasive Cardiology,2006,144:264.
10Sekiguchi M,Hoshizaki H,Adachi H,et al.Effects of antiplatelet agents on subacute thrombosis and restenosis after successful coronary stenting:A randomized comparison of ticlopidine and cilostazol[J].Circ J,2004,68(7):610.
二级参考文献12
1Boczkowska-Gaik E, Tendera M, Pathogenesis and treatment of acute coronary syndromes. Wiad lek, 2005,58 : 425-432.
2Ting HH, Yang EH, Rihal CS. Narrative review l reperfusion strategies for ST-segment elevation myocardial infarction. Ann Intern Med, 2006,145 : 610-617.
3Larson DM, Henry TD. Reperfusion options in ST-elevation myocardial infarction patients with expected delays, Curt Cardiol Rep, 2008,10:415-423.
4De la Cruz KI, Tsai PI, Cohn WE, et al. Revascularization treatment recommendations based on atherosclerotic disease distribution:coronary artery bypass grafting versus stenting. Curt Atheroseler Rep, 2008,10 : 434-437.
5Biondi-Zoccai GG, Lotrionte M, Moretti C, et al. A collaboratsystematic anatomy systematic review and meta-analysis on 1278 patients undergiong percutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am Heart J, 2008,155 : 274-283.
6Zimarino M,Sacchetta D,Renda G,et al. Facilitated PCI, rationale, current evidence, open question,and future directions. J Cardiovasc Pharmacol, 2008,51 : 3-10.
7Cohen M, Diez J, Frv E, et al. Strategies for optimizing outcomes in the NSTE-ACS patient the CATH(cardiac catheterization and antithrombotic therapy in the hospital)Clinical Consensus Panel Report. J Invasive Cardiol, 2006,18:617-639.
3Kritchevsky SB ,Cesari M ,Pahor M. Inflammatory markers and cardio- vascular health in older adults [J]. Cardiovasc Res, 2005,66 (2) :265-275.
4Hansson GK. Inflammation ,atherosclerosis,and coronary artely disease[J]. N Engl J Med ,2005,352(16) : 1685-1695.
5Williams MA, Fleg JL, Ades PA,et al. Secondary prevention of coronaryheart disease in the elderly(with emphasis on patients>or=-75 years of age) : an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise,Cardiac Rehabilitation, and Prevention[J]. Cireulation ,2002,105(14) : t735-1743.
6Jarrett PG, Rockwood K, Carver D, et al. Illness presentation in elderly patiemstJ]. Arch Intern Med, 1995,155 (10) : 1060-1064.
7Dulin BR, Krum H. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence[J]. Curt Opin Cardiol,2006,2 l (4) : 393-399.
8Cinello M, Nucifora G, Bertolissi M, et al. American College of Cardiolo- gy/American Heart Association perioperative assessment guidelines for noncardiac surgery reduces cardiologic resource utilization preserving a favourable clinical outcome[J]. J Cardiovasc Med (Hagerstown) ,2007,8 ( 11 ) : 882-888.
9Repin AN, Syrkina AG, Markov VA. System thrombolytic therapy in acute myocardial infarction in the elderly[J]. Klin Med (Mosk), 2006,84 (3) : 39-43.
10Katra RP, Oya T, Hocker GS, et al. Ryanodine receptor dysfunction and triggered activity in the heart[J]. Am J Physiol Heart Circ Physiol, 2007,292 (5) :2144-2151.
